car t-cells Search Results


1bb costimulatory domain  (BPS Bioscience)
94
BPS Bioscience 1bb costimulatory domain
1bb Costimulatory Domain, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/Anti-CD19+CAR-T+Cells/pmc12363560-160-5-11
Average 94 stars, based on 1 article reviews
1bb costimulatory domain - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
car-t cells  (SOTIO Inc)
90
SOTIO Inc car-t cells
Selected published clinical trials of CAR-T cells, NK cells, TCR-T cells, and TILs as treatments for lung cancer or malignant pleural mesothelioma.
Car T Cells, supplied by SOTIO Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/car+t+cells/pmc11718842-51-2-36
Average 90 stars, based on 1 article reviews
car-t cells - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
anti–egfr chimeric antigen receptor (car)-t cells  (ProMab Inc)
90
ProMab Inc anti–egfr chimeric antigen receptor (car)-t cells
Selected published clinical trials of CAR-T cells, NK cells, TCR-T cells, and TILs as treatments for lung cancer or malignant pleural mesothelioma.
Anti–Egfr Chimeric Antigen Receptor (Car) T Cells, supplied by ProMab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/anti+egfr+chimeric+antigen+receptor++car++t+cells/pmc07293070-37-0-9
Average 90 stars, based on 1 article reviews
anti–egfr chimeric antigen receptor (car)-t cells - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
car-t cells  (Theravectys s.a)
90
Theravectys s.a car-t cells
Selected published clinical trials of CAR-T cells, NK cells, TCR-T cells, and TILs as treatments for lung cancer or malignant pleural mesothelioma.
Car T Cells, supplied by Theravectys s.a, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/car+t+cells/10__1038_slash_mt__2015__74-3426-24-0
Average 90 stars, based on 1 article reviews
car-t cells - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
car-t cells  (CARsgen Therapeutics Co Ltd)
90
CARsgen Therapeutics Co Ltd car-t cells
Selected published clinical trials of CAR-T cells, NK cells, TCR-T cells, and TILs as treatments for lung cancer or malignant pleural mesothelioma.
Car T Cells, supplied by CARsgen Therapeutics Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/car+t+cells/pm37046312-323-13-24
Average 90 stars, based on 1 article reviews
car-t cells - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
car t-cell immunotherapy  (Lyell Immunopharma)
90
Lyell Immunopharma car t-cell immunotherapy
Selected published clinical trials of CAR-T cells, NK cells, TCR-T cells, and TILs as treatments for lung cancer or malignant pleural mesothelioma.
Car T Cell Immunotherapy, supplied by Lyell Immunopharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/car+t+cells+therapies/pmc08178409-14-9-17
Average 90 stars, based on 1 article reviews
car t-cell immunotherapy - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
car t-cell products  (Immunochina Pharmaceuticals Co Ltd)
90
Immunochina Pharmaceuticals Co Ltd car t-cell products
Characteristics of the 71 pediatric patients
Car T Cell Products, supplied by Immunochina Pharmaceuticals Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/im19+car+t+cells/pmc07252549-512-11-4
Average 90 stars, based on 1 article reviews
car t-cell products - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
gpc3 lung squamous cell carcinoma  (CARsgen Therapeutics Co Ltd)
90
CARsgen Therapeutics Co Ltd gpc3 lung squamous cell carcinoma
Clinical trials in treatment of solid tumors in China by CAR-T cells
Gpc3 Lung Squamous Cell Carcinoma, supplied by CARsgen Therapeutics Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/ct017+car+gpc3+t+cells/pmc06854376-22-0-7
Average 90 stars, based on 1 article reviews
gpc3 lung squamous cell carcinoma - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
anti-cd37 chimeric antigen receptor t cells  (Scarfo Inc)
90
Scarfo Inc anti-cd37 chimeric antigen receptor t cells
Clinical trials in treatment of solid tumors in China by CAR-T cells
Anti Cd37 Chimeric Antigen Receptor T Cells, supplied by Scarfo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/car+t+cells/pm37626420-1214-14-0
Average 90 stars, based on 1 article reviews
anti-cd37 chimeric antigen receptor t cells - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
chimeric antigen receptor engineered foxp3+ regulatory t cells (car-treg)  (TxCell Inc)
90
TxCell Inc chimeric antigen receptor engineered foxp3+ regulatory t cells (car-treg)
Clinical trials in treatment of solid tumors in China by CAR-T cells
Chimeric Antigen Receptor Engineered Foxp3+ Regulatory T Cells (Car Treg), supplied by TxCell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/chimeric+antigen+receptor+engineered+foxp3++regulatory+t+cells++car+treg+/pmc05215402-13-13-0
Average 90 stars, based on 1 article reviews
chimeric antigen receptor engineered foxp3+ regulatory t cells (car-treg) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
car t cells pd674  (ProMab Inc)
90
ProMab Inc car t cells pd674
Clinical trials in treatment of solid tumors in China by CAR-T cells
Car T Cells Pd674, supplied by ProMab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/car+t+cells+pd674/pm40595437-437-43-52
Average 90 stars, based on 1 article reviews
car t cells pd674 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
wl276 car-t cells  (Immunochina Pharmaceuticals Co Ltd)
90
Immunochina Pharmaceuticals Co Ltd wl276 car-t cells
Current clinical trials exploring CAR T-cell therapy in GBM. Information obtained from ClinicalTrials.gov, accessed on 15 January 2025.
Wl276 Car T Cells, supplied by Immunochina Pharmaceuticals Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/wl276+car+t+cells/pmc11816167-18-20-10
Average 90 stars, based on 1 article reviews
wl276 car-t cells - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Selected published clinical trials of CAR-T cells, NK cells, TCR-T cells, and TILs as treatments for lung cancer or malignant pleural mesothelioma.

Journal: Cancers

Article Title: Engineered Cellular Therapies for the Treatment of Thoracic Cancers

doi: 10.3390/cancers17010035

Figure Lengend Snippet: Selected published clinical trials of CAR-T cells, NK cells, TCR-T cells, and TILs as treatments for lung cancer or malignant pleural mesothelioma.

Article Snippet: NCT05120271 , CAR-T cells preceded by conditioning with cyclophosphamide + fludarabine , Autologous , 5 dose levels (doses NR) , Advanced GPC3-positive solid tumors, including squamous cell carcinoma of the lung. , GPC3 , 1/2 , Sotio Biotech Inc..

Techniques: Clinical Proteomics, Recombinant, Control, Expressing, Knock-Out, Derivative Assay, Cell Counting, Ex Vivo

Actively recruiting clinical trials testing cell therapies for lung cancer or mesothelioma available on clinicaltrials.gov .

Journal: Cancers

Article Title: Engineered Cellular Therapies for the Treatment of Thoracic Cancers

doi: 10.3390/cancers17010035

Figure Lengend Snippet: Actively recruiting clinical trials testing cell therapies for lung cancer or mesothelioma available on clinicaltrials.gov .

Article Snippet: NCT05120271 , CAR-T cells preceded by conditioning with cyclophosphamide + fludarabine , Autologous , 5 dose levels (doses NR) , Advanced GPC3-positive solid tumors, including squamous cell carcinoma of the lung. , GPC3 , 1/2 , Sotio Biotech Inc..

Techniques: Clinical Proteomics, Expressing, Injection, Produced, Ex Vivo, CRISPR, In Vitro, Membrane, Mutagenesis, Recombinant

Characteristics of the 71 pediatric patients

Journal: Blood Advances

Article Title: Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

doi: 10.1182/bloodadvances.2020001466

Figure Lengend Snippet: Characteristics of the 71 pediatric patients

Article Snippet: We also thank the Immunochina Pharmaceuticals Co., Ltd., which provided the CAR T-cell products.

Techniques:

CR rate, CRS, neurotoxicity, and CAR peak (N = 110)

Journal: Blood Advances

Article Title: Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

doi: 10.1182/bloodadvances.2020001466

Figure Lengend Snippet: CR rate, CRS, neurotoxicity, and CAR peak (N = 110)

Article Snippet: We also thank the Immunochina Pharmaceuticals Co., Ltd., which provided the CAR T-cell products.

Techniques: Mutagenesis

Characteristics of patients bridging into allo-HSCT vs those not bridging into allo-HSCT after CAR T-cell therapy

Journal: Blood Advances

Article Title: Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

doi: 10.1182/bloodadvances.2020001466

Figure Lengend Snippet: Characteristics of patients bridging into allo-HSCT vs those not bridging into allo-HSCT after CAR T-cell therapy

Article Snippet: We also thank the Immunochina Pharmaceuticals Co., Ltd., which provided the CAR T-cell products.

Techniques: Mutagenesis, Irradiation

Multivariable analysis of OS and LFS for subgroups

Journal: Blood Advances

Article Title: Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

doi: 10.1182/bloodadvances.2020001466

Figure Lengend Snippet: Multivariable analysis of OS and LFS for subgroups

Article Snippet: We also thank the Immunochina Pharmaceuticals Co., Ltd., which provided the CAR T-cell products.

Techniques: Mutagenesis

Clinical trials in treatment of solid tumors in China by CAR-T cells

Journal: International Journal of Biological Sciences

Article Title: Current Progress in CAR-T Cell Therapy for Solid Tumors

doi: 10.7150/ijbs.34213

Figure Lengend Snippet: Clinical trials in treatment of solid tumors in China by CAR-T cells

Article Snippet: GPC3 , Lung squamous cell carcinoma , Carsgen Therapeutics, Ltd. , Phase 1 , NCT02876978 , 2016.

Techniques: Clinical Proteomics

Current clinical trials exploring CAR T-cell therapy in GBM. Information obtained from ClinicalTrials.gov, accessed on 15 January 2025.

Journal: Cancers

Article Title: Immune Resistance in Glioblastoma: Understanding the Barriers to ICI and CAR-T Cell Therapy

doi: 10.3390/cancers17030462

Figure Lengend Snippet: Current clinical trials exploring CAR T-cell therapy in GBM. Information obtained from ClinicalTrials.gov, accessed on 15 January 2025.

Article Snippet: NCT06691308 [ ] , 2024– , Cheng et al. Beijing Immunochina Medical Science & Technology , I , 6 , WL276 CAR-T cells , rGBM or pGBM , No results posted , Not yet recruiting.

Techniques: Clinical Proteomics, Biomarker Discovery